✦ LIBER ✦

Minimizing infliximab toxicity in the treatment of inflammatory bowel disease

✍ Scribed by A. Orlando; F. Mocciaro; G. Civitavecchia; D. Scimeca; M. Cottone

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of infliximab treatment in pediat

✍ Scarbrough, Mark; Calabro, Cheryl; Carpenter, Ellen; Bendorf, Kathy; Friesen, Cr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 266 KB

P140 - Adherence to scheduled infliximab

✍ I. Theodoropoulos; A. Smyrnidis; C. Karakoidas; E. Archavlis; K. Papamichael; N. 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 58 KB

Infliximab for treatment of pyoderma gan

✍ Miguel Regueiro; John Valentine; Scott Plevy; Mark R Fleisher; Gary R Lichtenste 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

P-040: Personalized infliximab treatment

✍ Carlsen, K.; Jakobsen, C.; Hansen, L.; Paerregaard, A.; Munkholm, P.; Wewer, V. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 46 KB

Inflammatory Bowel Disease || Innovation

✍ Cohen, Russell D. 📂 Article 📅 2011 🏛 Humana Press ⚖ 94 KB

Treatment of Immune-Mediated Extraintest

✍ Barrie, Arthur; Plevy, Scott 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 122 KB